25 June 2019 in Dermatologic Therapy
8 March 2021 in Journal of Cosmetic Dermatology
21 November 2020 in Dermatologic Therapy
AAAyşe Şermin Filiz Acıpayam
Ayşe Şermin Filiz Acıpayam
8 March 2021 in Journal of Cosmetic Dermatology
Aim: To investigate whether acne treatment agent systemic isotretinoin causes susceptibility to COVID‐19 disease.Material and method: Patients admitted to a single center due to acne between March 2020 and December 2020 were included. A retrospective analysis was conducted on the medical records of acne patients receiving systemic isotretinoin or topical treatments. The patients with PCR‐confirmed SARS‐CoV‐2 infection were recorded.Results: 302 patients who used isotretinoin and 329 patients who used topical treatment were included in the study. No statistically significant difference was found between the groups in terms of age (p = 0.151). It was found that of the 302 patients who used isotretinoin, 33 had PCR test for SARS‐CoV‐2 and two of these had PCR positivity, while of the 329 patients who received topical treatment, 45 had PCR test and five of these had PCR positivity. No statistically significant difference was found between the groups in terms of having SARS‐CoV‐2 positivity with PCR (p = 0.692).Conclusion: Susceptibility to COVID‐19 disease was not observed in patients using systemic isotretinoin.
30 December 2021 in Rheumatology
Objectives To evaluate the frequency and clinical course of coronavirus disease 2019 (COVID-19) in patients with Behçet’s disease (BD). Material and methods The study included patients diagnosed with BD according to the International Study Group for BD criteria who were being followed up in...
5 February 2022 in Journal of Cosmetic Dermatology